NCT02357693View on ClinicalTrials.gov

Neurokinin Receptor Antagonist Associated to Ondansetron in PONV

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

Aprepitant

Aprepitant or placebo will be administered to the patient before surgery

Trial Locations (1)

01403010

Angela Maria Sousa, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER

NCT02357693 - Neurokinin Receptor Antagonist Associated to Ondansetron in PONV | Biotech Hunter | Biotech Hunter